91ÖÆƬ³§

1 Market Overview
1.1 Product Overview and Scope of Gene Editing
1.2 Classification of Gene Editing by Type
1.2.1 Overview: Global Gene Editing Market Size by Type: 2024 Versus 2030
1.2.2 Global Gene Editing Revenue Market Share by Type in 2030
1.2.3 Zinc finger nucleases (ZFNs)
1.2.4 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.5 CRISPR-Cas system
1.3 Global Gene Editing Market by Application
1.3.1 Overview: Global Gene Editing Market Size by Application: 2024 Versus 2030
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Gene Editing Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Gene Editing Market Drivers
1.5.2 Gene Editing Market Restraints
1.5.3 Gene Editing Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Gene Editing Product and Solutions
2.1.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Gene Editing Product and Solutions
2.2.4 Merck Recent Developments and Future Plans
2.3 Horizo​​n Discovery
2.3.1 Horizo​​n Discovery Details
2.3.2 Horizo​​n Discovery Major Business
2.3.3 Horizo​​n Discovery Gene Editing Product and Solutions
2.3.4 Horizo​​n Discovery Recent Developments and Future Plans
2.4 Sangamo BioSciences
2.4.1 Sangamo BioSciences Details
2.4.2 Sangamo BioSciences Major Business
2.4.3 Sangamo BioSciences Gene Editing Product and Solutions
2.4.4 Sangamo BioSciences Recent Developments and Future Plans
2.5 Integrated DNA Technologies
2.5.1 Integrated DNA Technologies Details
2.5.2 Integrated DNA Technologies Major Business
2.5.3 Integrated DNA Technologies Gene Editing Product and Solutions
2.5.4 Integrated DNA Technologies Recent Developments and Future Plans
2.6 Lonza
2.6.1 Lonza Details
2.6.2 Lonza Major Business
2.6.3 Lonza Gene Editing Product and Solutions
2.6.4 Lonza Recent Developments and Future Plans
2.7 New England Biolabs
2.7.1 New England Biolabs Details
2.7.2 New England Biolabs Major Business
2.7.3 New England Biolabs Gene Editing Product and Solutions
2.7.4 New England Biolabs Recent Developments and Future Plans
2.8 OriGene Technologies
2.8.1 OriGene Technologies Details
2.8.2 OriGene Technologies Major Business
2.8.3 OriGene Technologies Gene Editing Product and Solutions
2.8.4 OriGene Technologies Recent Developments and Future Plans
2.9 Transposagen Biopharmaceuticals
2.9.1 Transposagen Biopharmaceuticals Details
2.9.2 Transposagen Biopharmaceuticals Major Business
2.9.3 Transposagen Biopharmaceuticals Gene Editing Product and Solutions
2.9.4 Transposagen Biopharmaceuticals Recent Developments and Future Plans
2.10 Editas Medicine
2.10.1 Editas Medicine Details
2.10.2 Editas Medicine Major Business
2.10.3 Editas Medicine Gene Editing Product and Solutions
2.10.4 Editas Medicine Recent Developments and Future Plans
2.11 CRISPR Therapeutics
2.11.1 CRISPR Therapeutics Details
2.11.2 CRISPR Therapeutics Major Business
2.11.3 CRISPR Therapeutics Gene Editing Product and Solutions
2.11.4 CRISPR Therapeutics Recent Developments and Future Plans
2.12 RGen Solutions
2.12.1 RGen Solutions Details
2.12.2 RGen Solutions Major Business
2.12.3 RGen Solutions Gene Editing Product and Solutions
2.12.4 RGen Solutions Recent Developments and Future Plans
2.13 Sigma-Aldrich
2.13.1 Sigma-Aldrich Details
2.13.2 Sigma-Aldrich Major Business
2.13.3 Sigma-Aldrich Gene Editing Product and Solutions
2.13.4 Sigma-Aldrich Recent Developments and Future Plans
2.14 GeneCopoeia
2.14.1 GeneCopoeia Details
2.14.2 GeneCopoeia Major Business
2.14.3 GeneCopoeia Gene Editing Product and Solutions
2.14.4 GeneCopoeia Recent Developments and Future Plans
2.15 Genscript Biotech
2.15.1 Genscript Biotech Details
2.15.2 Genscript Biotech Major Business
2.15.3 Genscript Biotech Gene Editing Product and Solutions
2.15.4 Genscript Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Editing Revenue and Share by Players (2024 & 2030)
3.2 Gene Editing Players Head Office, Products and Services Provided
3.3 Gene Editing Mergers & Acquisitions
3.4 Gene Editing New Entrants and Expansion Plans
4 Global Gene Editing Forecast by Region
4.1 Global Gene Editing Market Size by Region: 2024 VS 2030
4.2 Global Gene Editing Market Size by Region, (2024-2030)
4.3 North America
4.3.1 Key Companies of Gene Editing in North America
4.3.2 Current Situation and Forecast of Gene Editing in North America
4.3.3 North America Gene Editing Market Size and Prospect (2024-2030)
4.4 Europe
4.4.1 Key Companies of Gene Editing in Europe
4.4.2 Current Situation and Forecast of Gene Editing in Europe
4.4.3 Europe Gene Editing Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
4.5.1 Key Companies of Gene Editing in Asia-Pacific
4.5.2 Current Situation and Forecast of Gene Editing in Asia-Pacific
4.5.3 Asia-Pacific Gene Editing Market Size and Prospect (2024-2030)
4.5.4 China
4.5.5 Japan
4.5.6 South Korea
4.6 South America
4.6.1 Key Companies of Gene Editing in South America
4.6.2 Current Situation and Forecast of Gene Editing in South America
4.6.3 South America Gene Editing Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
4.7.1 Key Companies of Gene Editing in Middle East & Africa
4.7.2 Current Situation and Forecast of Gene Editing in Middle East & Africa
4.7.3 Middle East & Africa Gene Editing Market Size and Prospect (2024-2030)
5 Market Size Segment by Type
5.1 Global Gene Editing Market Forecast by Type (2024-2030)
5.2 Global Gene Editing Market Share Forecast by Type (2024-2030)
6 Market Size Segment by Application
6.1 Global Gene Editing Market Forecast by Application (2024-2030)
6.2 Global Gene Editing Market Share Forecast by Application (2024-2030)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer